Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty.
about
Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markersStem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applicationsTracking of stem cells in vivo for cardiovascular applications.Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applicationsBone marrow cells for cardiac regeneration and repair: current status and issues.Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesSerum-free and xenobiotic-free preservation of cultured human limbal epithelial cells.Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques.Stem cell therapy for the heart.Cellular cardiomyoplasty for myocardial regeneration.Stem cells for the ischaemic heart.Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells.Release of growth factors and the effect of age, sex, and severity of injury after long bone fracture. A preliminary reportGene and cell therapy for chronic ischaemic heart disease.Somatic stem cell transplantation for the failing heart.Present and future of stem cells for cardiovascular therapy.Genesis of myocardial repair with cardiac progenitor cells and tissue engineeringCardiovascular cell therapy and endogenous repairCharacterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions.Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy.An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in vitro.Cell-based therapy for heart failure: skeletal myoblasts.Cellular cardiac regenerative therapy in which patients?Predifferentiated adult stem cells and matrices for cardiac cell therapy.Skeletal myoblasts for cardiac repair.Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans.Clinical application of adult stem cells for therapy for cardiac disease.Creating the bioartificial myocardium for cardiac repair: challenges and clinical targets.Serum albumin as a local therapeutic agent in cell therapy and tissue engineering.Adipose Tissue Derived Multipotent Mesenchymal Stromal Cells Can Be Isolated Using Serum-free Media.Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats-a serial MRI study.Development of bioartificial myocardium using stem cells and nanobiotechnology templates.A human plasma derived supplement preserves function of human vascular cells in absence of fetal bovine serum.Isolation, characterization, and gene expression analysis of Wharton's jelly-derived mesenchymal stem cells under xeno-free culture conditions."Humanized" stem cell culture techniques: the animal serum controversyA G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes.Autologous serum enhances cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells in the presence of transforming growth factor-β1 (TGF-β1).Stem cell experiments and initial clinical trial of cellular cardiomyoplasty.
P2860
Q24810258-190D5717-8C0D-4677-A68C-AF014B54AD0AQ26865849-2DE2C12C-39C6-4300-83A1-ABC58595E18AQ30443013-105F2090-E094-4869-97B9-F77EADA4D4D2Q30479159-C7109ADD-4DE1-4763-8C26-10724E3F867DQ33254416-DBF18C76-013F-4183-8037-4627345DA155Q33363566-8371E6C0-5291-4278-9550-851D98E2A64BQ33518056-C82D2D11-A959-4B96-8877-A168E1C41303Q34981433-67EC7480-C5CD-4580-90E8-51ABD294D943Q35143610-2071161B-1F0A-4367-BFFA-CB9F8DF53FD8Q35691795-0B5B62CC-D75E-4A12-93DF-96026BE9B299Q35980614-26B597CE-1922-45C7-BDC7-1DB1090B17A9Q36236544-4C2FE877-7569-4440-98DC-27DCF620A5F3Q36446920-A7243917-33E4-44EA-AB1E-84A12D04C665Q36462071-AC5A6FB2-2F8F-4301-AA98-67B7ADFE974EQ36645611-C9AB90A3-B000-4973-907C-72C6D226E717Q36675432-C55877A5-B07F-4E66-9EED-439EBB94F40FQ36902543-E320E0CC-BE13-42CF-86C1-C9F80EA7C06EQ36939430-61DC52E0-4D50-4ED9-A4A0-E56BDE9A587FQ36982525-1C685A57-4E48-46C1-9950-5FB7E9D9392DQ37060620-0107729D-1F34-4804-971A-609883BE09B2Q37120340-E78275FD-A952-4ADB-9EA1-0ED9BA8F53CAQ37194115-34C9EDDE-8CB8-43A4-A839-FE1EE369D965Q37409312-A1EBC80A-0F36-4508-9679-374A0B84C442Q37509252-549EE2EC-D813-4092-9CFA-6C794ABF0749Q37578550-A2E800D0-3F32-47F8-B9B8-49EB182676B0Q37685810-19935DB9-9CCC-4439-8E3E-684DDC8DFEF3Q37810057-1A0E983B-F2FC-4514-B114-1FBFC9B2C8FCQ37977128-6934465B-DFF5-47D9-9CE3-289E0223A0A9Q38114986-3CFCE669-49B0-4BB6-A5A5-4C3C694F741AQ38161527-246699C8-8908-4B3F-98AC-557325A9DC93Q39012336-6C6946C5-5857-491A-BF55-7AD0F29DAA82Q39341467-2B064A17-259A-44B6-A5CB-CEDCE8FCD1D5Q39712813-1C833CF0-3AC7-40D0-AAC2-1D4714A4FB43Q39791530-841EC699-2FFE-42EA-8539-DCDEB761D1CDQ41375755-B9EE303E-B6C5-4222-89DF-8BBBCA680E38Q42144900-F030E224-6804-4342-9247-C8ABB22ED2A2Q42735346-8AFFD971-BECB-4C37-9250-1BFE9DE1CED7Q42914922-A95EADC3-9653-44EC-A891-D757393A1C21Q46607429-9D71368D-F140-48E7-BA5A-111CFD77EE07Q50714933-791F1BBF-B496-4790-AEB5-3789CCC9436F
P2860
Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@en
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@nl
type
label
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@en
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@nl
prefLabel
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@en
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@nl
P2093
P1476
Autologous human serum for cel ...... s in cellular cardiomyoplasty.
@en
P2093
Alberto Juffe
Esther Rendal
Jesus Herreros
Jorge Genovese
Jorge Trainini
Juan C Chachques
P304
P356
10.1016/S0167-5273(04)90009-5
P407
P478
95 Suppl 1
P577
2004-06-01T00:00:00Z